{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:23:27Z","timestamp":1787243007153,"version":"build-2736575974"},"reference-count":50,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2014,2,27]]},"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with high Rockall scores have increased risk of ulcer rebleeding after 3-day esomeprazole infusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether double oral esomeprazole given after a 3-day esomeprazole infusion decreases ulcer rebleeding for patients with high Rockall scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We prospectively enrolled 293 patients with peptic ulcer bleeding who had achieved endoscopic haemostasis. After a 3-day esomeprazole infusion, patients with Rockall scores \u22656 were randomised into the oral double-dose group (n=93) or the oral standard-dose group (n=94) to receive 11\u2005days of oral esomeprazole 40\u2005mg twice daily or once daily, respectively. The patients with Rockall scores &lt;6 served as controls (n=89); they received 11\u2005days of oral esomeprazole 40\u2005mg once daily. Thereafter, all patients received oral esomeprazole 40\u2005mg once daily for two more weeks until the end of the 28-day study period. The primary end point was peptic ulcer rebleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among patients with Rockall scores \u22656, the oral double-dose group had a higher cumulative rebleeding-free proportion than the oral standard-dose group (p=0.02, log-rank test). The proportion of patients free from recurrent bleeding during the 4th\u201328th day in the oral double-dose group remained lower than that of the group with Rockall scores &lt;6 (p=0.03, log-rank test). Among patients with Rockall scores \u22656, the rebleeding rate was lower in the oral double-dose group than in the oral standard-dose group (4th\u201328th day: 10.8% vs 28.7%, p=0.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Double oral esomeprazole at 40\u2005mg twice daily after esomeprazole infusion reduced recurrent peptic ulcer bleeding in high-risk patients with Rockall scores \u22656.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NCT01591083.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2013-306531","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T01:15:33Z","timestamp":1395450933000},"page":"1864-1872","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study"],"prefix":"10.1136","volume":"63","clinical-trial-number":[{"clinical-trial-number":"nct01591083","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hsiu-Chi","family":"Cheng","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Tai","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lun","family":"Chang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chun","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Shyang","family":"Sheu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"key":"2025120519444888000_63.12.1864.1","first-page":"206","article-title":"Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study","volume":"90","author":"Longstreth","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2025120519444888000_63.12.1864.2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02087411"},{"key":"2025120519444888000_63.12.1864.3","first-page":"568","article-title":"Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities","volume":"90","author":"Yavorski","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"2025120519444888000_63.12.1864.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.687"},{"key":"2025120519444888000_63.12.1864.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.3.316"},{"key":"2025120519444888000_63.12.1864.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90607-8"},{"key":"2025120519444888000_63.12.1864.7","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-925313"},{"key":"2025120519444888000_63.12.1864.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2821-8"},{"key":"2025120519444888000_63.12.1864.9","first-page":"S16","article-title":"Endoscopic risk factors for bleeding peptic ulcer","volume":"36","author":"Johnston","year":"1990","journal-title":"Gastrointest Endosc"},{"key":"2025120519444888000_63.12.1864.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(94)70253-5"},{"key":"2025120519444888000_63.12.1864.11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.6.746"},{"issue":"(Suppl 2)","key":"2025120519444888000_63.12.1864.12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2007-1018418","article-title":"Prognostic factors in upper G.I. bleeding","volume":"18","author":"de Dombal","year":"1986","journal-title":"Endoscopy"},{"key":"2025120519444888000_63.12.1864.13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.10.1389"},{"key":"2025120519444888000_63.12.1864.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(96)70085-8"},{"key":"2025120519444888000_63.12.1864.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00055-2"},{"key":"2025120519444888000_63.12.1864.16","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3180a5be63"},{"key":"2025120519444888000_63.12.1864.17","first-page":"2270","article-title":"Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion","volume":"50","author":"Cheng","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"2025120519444888000_63.12.1864.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2759-6"},{"key":"2025120519444888000_63.12.1864.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04049.x"},{"key":"2025120519444888000_63.12.1864.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2009.04.014"},{"key":"2025120519444888000_63.12.1864.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2012.02974.x"},{"key":"2025120519444888000_63.12.1864.22","doi-asserted-by":"publisher","DOI":"10.1038\/2261261a0"},{"key":"2025120519444888000_63.12.1864.23","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018827003641"},{"key":"2025120519444888000_63.12.1864.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05900.x"},{"key":"2025120519444888000_63.12.1864.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.006"},{"key":"2025120519444888000_63.12.1864.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04354.x"},{"key":"2025120519444888000_63.12.1864.27","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802538203"},{"key":"2025120519444888000_63.12.1864.28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.230292"},{"key":"2025120519444888000_63.12.1864.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)93143-0"},{"key":"2025120519444888000_63.12.1864.30","unstructured":"U.S. Food and Drug Administration. [cited 8 September 2013].http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/ucm225843.htm"},{"key":"2025120519444888000_63.12.1864.31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-7-200904070-00105"},{"key":"2025120519444888000_63.12.1864.32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2036.2002.01137.x","article-title":"Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding","volume":"16","author":"Sheu","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120519444888000_63.12.1864.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02281.x"},{"key":"2025120519444888000_63.12.1864.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(81)73155-9"},{"key":"2025120519444888000_63.12.1864.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02816-6"},{"key":"2025120519444888000_63.12.1864.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430501"},{"key":"2025120519444888000_63.12.1864.37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2008.11.010","article-title":"Non-NSAID non H. pylori ulcer disease","volume":"23","author":"Chow","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025120519444888000_63.12.1864.38","doi-asserted-by":"publisher","DOI":"10.1159\/000125316"},{"key":"2025120519444888000_63.12.1864.39","first-page":"S29","article-title":"Shortcomings of the first-generation proton pump inhibitors","volume":"13","author":"Tytgat","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025120519444888000_63.12.1864.40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.35.040195.001425"},{"key":"2025120519444888000_63.12.1864.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02943.x"},{"key":"2025120519444888000_63.12.1864.42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2036.1993.tb00125.x","article-title":"Does 40\u2005mg omerprazole daily offer additional benefit over 20\u2005mg daily in patients requiring more than 4\u2005weeks of treatment for symptomatic reflux oesophagitis?","volume":"7","author":"Bate","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120519444888000_63.12.1864.43","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00426.x"},{"key":"2025120519444888000_63.12.1864.44","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31803233b7"},{"key":"2025120519444888000_63.12.1864.45","first-page":"1532","article-title":"Optimal dosing of omeprazole 40\u2005mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls","volume":"91","author":"Kuo","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"2025120519444888000_63.12.1864.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02079.x"},{"key":"2025120519444888000_63.12.1864.47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/gut.21.4.324","article-title":"Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects","volume":"21","author":"Lam","year":"1990","journal-title":"Gut"},{"key":"2025120519444888000_63.12.1864.48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2165\/00003088-199529030-00005","article-title":"Geographic\/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19","volume":"29","author":"Bertilsson","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"2025120519444888000_63.12.1864.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb05199.x"},{"key":"2025120519444888000_63.12.1864.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2009.01.041"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2013-306531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:45:00Z","timestamp":1764992700000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2013-306531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,21]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,10,31]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1136\/gutjnl-2013-306531"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2013-306531","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,21]]}}}